Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...
Arcturus is advancing its vaccine and rare disease pipeline with significant developments. The initiation of a BARDA-funded Phase 1 study for bird flu, along with ongoing studies in cystic ...
SAN DIEGO, January 30, 2025--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious ...
The 1/11 portal on Jan. 11, 2025, is all about new beginnings in numerology Get ready to make all your dreams come true as Jan. 11 is a prime time to manifest. The date, which translates to the ...
The time has finally come: PlayStation Portal stock levels have leveled out in both the US and UK at all major retailers. We've been tracking the stock levels of the Portal particularly closely ...
If you're interested in exploring more stocks under $100 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Do you think that you can’t start ...
After hours: February 7 at 6:22:20 PM EST Loading Chart for ARCT ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results